Safety and Efficacy of Infliximab in Palmoplantar Psoriasis

NCT00629772 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Palmoplantar Psoriasis

Interventions

DRUG: Placebo
DRUG: Infliximab

Sponsor

Innovaderm Research Inc.

Collaborators

[object Object]